StonvexLoading…
StonvexCore line items from OVV's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $8.66B | $8.94B | $10.66B | $14.26B |
Operating Income | $1.13B | $1.58B | $2.86B | $3.85B |
Net Income | $1.24B | $1.13B | $2.08B | $3.64B |
EPS (Diluted) | $4.78 | $4.21 | $7.90 | $14.08 |
Total Assets | $20.39B | $19.25B | $19.99B | $15.06B |
Total Liabilities | $9.20B | $8.92B | $9.62B | $7.37B |
Cash & Equivalents | $35.00M | $42.00M | $3.00M | $5.00M |
Free Cash Flow OCF − CapEx | $1.50B | $1.42B | $1.42B | $2.04B |
Shares Outstanding | 253.30M | 260.40M | 271.70M | 245.70M |